Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock closed at 1.97 per share at the end of the most recent trading day (a 7.07% change compared to the prior day closing price) with a volume of 31.18M shares and market capitalization of 451.21M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 190 people. Inovio Pharmaceuticals Inc. CEO is J. Joseph Kim.

The one-year performance of Inovio Pharmaceuticals Inc. stock is -73.14%, while year-to-date (YTD) performance is -60.52%. INO stock has a five-year performance of -72.52%. Its 52-week range is between 1.6 and 10.33, which gives INO stock a 52-week price range ratio of 4.24%

Inovio Pharmaceuticals Inc. currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 1.14, a price-to-sale (PS) ratio of 308.40, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -60.83%, a ROC of -65.41% and a ROE of -73.26%. The company’s profit margin is -%, its EBITDA margin is -16 709.70%, and its revenue ttm is $1.40 Million , which makes it $0.01 revenue per share.

Of the last four earnings reports from Inovio Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.28 for the next earnings report. Inovio Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Inovio Pharmaceuticals Inc. is Hold (2.75), with a target price of $5.33, which is +170.56% compared to the current price. The earnings rating for Inovio Pharmaceuticals Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Inovio Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Inovio Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.98, ATR14 : 0.24, CCI20 : -114.62, Chaikin Money Flow : -0.08, MACD : -0.36, Money Flow Index : 55.38, ROC : -38.26, RSI : 30.80, STOCH (14,3) : 16.11, STOCH RSI : 0.53, UO : 38.78, Williams %R : -83.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Inovio Pharmaceuticals Inc. in the last 12-months were: Ann C. Miller (Option Excercise at a value of $0), David B. Weiner (Option Excercise at a value of $0), David B. Weiner (Sold 17 166 shares of value $44 212 ), Jacqueline E. Shea (Option Excercise at a value of $0), Jacqueline E. Shea (Sold 77 070 shares of value $771 471 ), Jay P. Shepard (Option Excercise at a value of $0), Kim Joseph Jong (Option Excercise at a value of $0), Laurent Humeau (Option Excercise at a value of $0), Laurent Humeau (Sold 20 635 shares of value $187 985 ), Lota S. Zoth (Option Excercise at a value of $0), Lota S. Zoth (Sold 4 561 shares of value $11 943 ), Peter D. Kies (Option Excercise at a value of $29 700), Peter D. Kies (Sold 43 750 shares of value $418 138 ), Roger D. Dansey (Option Excercise at a value of $0), Simon X. Benito (Option Excercise at a value of $8 800), Simon X. Benito (Sold 4 000 shares of value $14 860 ), Wendy L. Yarno (Option Excercise at a value of $0)